ASSSSMENT OF A NEW COMMERCIAL 3 WAVELENGTH OXIMETER

新型商用 3 波长血氧计的评估

• 批准号: 8362652
• 负责人: ALBERT Edward CERUSSI
• 金额: $ 0.51万
• 依托单位: UNIVERSITY OF CALIFORNIA-IRVINE
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-04-01 至 2012-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8362652
• 关键词: Biotechnology; Devices; Funding; Grant; Lasers; National Center for Research Resources; Noise; Patients; Performance; Principal Investigator; Research; Research Infrastructure; Resources; Signal Transduction; Source; System; Testing; Time; Tissues; United States National Institutes of Health; cost; instrument; photonics; prototype

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Hamamatsu Photonics has developed a prototype dual channel time domain tissue oximeter. Hamamatsu is currently searching for applications for which this device may be used. Tests of instrument signal-to-noise, stability, user and patient interfaces, and overall system performance will be assessed.

该子项目是利用资源的众多研究子项目之一 由 NIH/NCRR 资助的中心拨款提供。子项目的主要支持 并且子项目的主要研究者可能是由其他来源提供的， 包括其他 NIH 来源。 子项目可能列出的总成本 代表子项目使用的中心基础设施的估计数量， NCRR 赠款不直接向子项目或子项目工作人员提供资金。 Hamamatsu Photonics 开发了一款原型双通道时域组织血氧计。 滨松目前正在寻找可以使用该设备的应用程序。 将评估仪器信噪比、稳定性、用户和患者界面以及整体系统性能的测试。